Hope Therapeutics Acquires Cohen & Associates, Expanding Mental Health Network

Strategic Acquisition and Network Expansion

• 🤝 Hope Therapeutics and Interventional Psychiatry Network (owned by NRx Pharmaceuticals) have acquired a strategic interest in Cohen & Associates LLC.
• 🏥 This acquisition marks the incorporation of Cohen & Associates into the Hope network, aiming to expand clinical reach and capabilities.

Leadership and Specialization

• 🩺 Dr. Rebecca Cohen has been appointed as the new Medical Director at Hope Therapeutics.
• 🧠 Dr. Cohen will oversee medical standards of care across Hope's Florida locations, bringing her expertise as an interventional psychiatrist and psychopharmacologist.
• 🎯 Her specialization includes the treatment of mood and anxiety disorders, with a national reputation in Transcranial Magnetic Stimulation (TMS).

Mission and Impact

• ✨ The combined entity aims to remain at the forefront of life-transforming therapy for depression and PTSD.
• 🎯 A key goal is to rapidly expand access to these therapies, potentially impacting the 13 million Americans who contemplate suicide annually.
• 🚀 This partnership is set to strengthen Hope Therapeutics' leadership in advanced interventional psychiatry and mental health innovation.